Effectiveness of PET/CT in the preoperative evaluation of neck disease

Laryngoscope

Volumn 124, Issue 1, 2014, Pages 159-164

  Nguyen, Anthony ^a   Luginbuhl, Adam ^a   Cognetti, David ^a   Van Abel, Katie ^c   Bar Ad, Voichita ^b   Intenzo, Charles ^b   Keane, William ^a   Curry, Joseph ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

CT; FDG PET; MRI; PET CT; squamous cell carcinoma

Indexed keywords

ADULT; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; HEAD AND NECK NEOPLASMS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; ARTICLE; CT; FDG-PET; HEAD AND NECK TUMOR; PET/CT; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

CT; FDG-PET; MRI; PET/CT; SQUAMOUS CELL CARCINOMA;

EID: 84895847864     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24329     Document Type: Conference Paper

References (30)

1. Reproduced with permission from The NCCN Guidelines Version 1.2012 Head and Neck Cancer Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network, 2012. Available at: http://www.nccn.org. Accessed April 17, 2013.
2. Medina, J., et al. American Head and Neck Society practice guidelines. http://www.ahns.info/clinicalresources/guidelines.php. Accessed Jan 2010.
3. Jones J, Farag I, Hain S, et al. Positron emission tomography in the management of oro-pharyngeal cancer. Eur J Surg Oncol 2005; 31: 170-176.
4. Krabbe C, Pieter D, Pruim J, et al. FDG PET in oral and oropharyngeal cancer: value for confirmation of N0 neck and detection of occult metastases. Oral Oncol 2008; 44: 31-36.
5. Nahmia, C, Carlson E, Duncan L,. et al. Positron Emission Tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral /head and neck cancer. J Oral Maxillofac Surg 2007; 65: 2524-2535.
6. Fogh SE, Kubicek GJ, Champ C, et al. Value of fluoro-2-deoxy-D-glucose- positron emission tomography for detecting metastatic lesions in head and neck cancer. Am J Clin Oncol 2012; 35: 311-315.
7. Bruschini P, Giogetti A, Bruschini L, et al. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT. Acta Otorhinolaryngo Ital 2003; 23: 446.
8. Fogh SE, Gregory JK, Champ C, Intenzo C, Axelrod R, Keane WM, Machtay MM,. Value of flouro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancers. Am J Clin Oncol 2012; 35: 311-315.
9. Waltonen JD, Ozer E, Hall NC, et al. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg 2009; 135: 1024-1029.
10. Van der Brekel MW, van der Waal I, Meijer CJ, et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996; 106: 987-991.
11. Wax M, Myers L, Gona J,. et al. The role of PET in the evaluation of the N-positive neck. Otolaryngol Head and Neck Surg 2003; 129: 163-167.
12. Schwartz DL, Ford E, Rajendran J, et al. FDG-PET/CT imaging for preradiotherapy staging of head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005; 61: 129-136.
13. Adams S, Baum RP, Stuckensen T, et al. Prospective comparison of 18FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998; 25: 1255.
14. Kresnik E, Mikosch P, Gallowitsch H,. et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001; 28: 816-821.
15. Sigg M, Steinert H, Gratz K, et al. Staging of head and neck tumors: PET compared with physical examination and conventional imaging modalities. J Oral Maxillofac Surg 2003; 61: 1022-1029.
16. Pohar S, Brown R, Newman N, et al. What does PET imaging add to conventional staging of head and neck cancer patients? Int J Radiat Oncol Biol Phys 2007; 68: 383-387.
17. Nguyen N, Kaushik A, Wolverson M, et al. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study. Acta Oncologica 2011; 50: 670-677.
18. Murakami R, Uozumi H, Hirai T, et al. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007; 68: 377-382.
19. Mukherji SK, Armao D, Joshi VM,. Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect. Head Neck 2001; 23: 995.
20. Woolgar JA, Beirne J., Vaughan E., et al. Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg 1995; 24: 30-37.
21. Shingaki S, Suzuki I, Nakajima T, et al. Computed tomographic evaluation of lymph node metastasis in head and neck carcinomas. J Craniomaxillofac Surg 1995; 23: 233-237.
22. Vermeesch H, Loose D, Ham H, et al. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers. Eur J Nucl Med Mol Imaging 2003; 12: 1689-1700.
23. Isles MG, McConkey C, Mehanna HM,. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008; 33: 210-222.
24. Kastrinidis N, Kuhn F, Hany T, et al. 18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma (HNSCC). Laryngoscope 2013; 123: 1210-1215. doi: 10.1002/lary.23944. Epub 2013.
25. Farwell G, Futran N,. PET in Otolaryngology-Head and Neck Surgery: Where, When, Why, and How. Presented at the Academy of Otolaryngology, Washington, DC, September 2012.
26. Ozer E, Naiboglu B, Meacham R, et al. The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol 2012; 269: 2411.
27. Stoeckli SJ, Steinert H, Pfaltz M, et al. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 2002; 24: 345-349.
28. Visser EP, Boermann OC, Oyen WJ,. SUV from silly useless value to smart uptake value. J Nucl Med 2010; 51: 173.
29. Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head and Neck Surg 2008; 143: 536-538.
30. Stuckenen T, Kovacs AF, Adams S, et al. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison: PET, ultrasound, CT, and MRI. J Craniomaxillofac Surg 2000; 28: 319-324.